R-3750 in Patients with Mild to Moderate Ulcerative Colitis

Recruiting

Phase 1

R-3750 in Patients with Mild to Moderate Ulcerative ColitisR-3750 in Patients with Mild to Moderate Ulcerative Colitis

Sponsor:

Rise Therapeutics LLC

Code:

NCT05666960

Conditions

Ulcerative Colitis Chronic Mild

Ulcerative Colitis Chronic Moderate

Ulcerative Colitis Chronic

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

R-3750

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-02. This information was provided to ClinicalTrials.gov by Rise Therapeutics LLC on 2025-03-25.